Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.73 |
| ▸ | TAS1R3 | Q7RTX0 | 6/20 | 0.67 |
| ▸ | TAS1R1 | Q7RTX1 | 6/20 | 0.67 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.60 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.60 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.60 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.60 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.60 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | RECQL | P46063 | 1/20 | 0.58 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.56 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.56 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.56 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.56 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.56 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.56 |
| ▸ | THRB | P10828 | 2/20 | 0.55 |
| ▸ | ATM | Q13315 | 1/20 | 0.55 |
| ▸ | GSK3B | P49841 | 1/20 | 0.54 |
| ▸ | F3 | P13726 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL402130 | 1.00 | SMN1; SMN2 (0.73) | SMN1; SMN2TAS1R3TAS1R1HDAC3HDAC1 | |
| SCHEMBL1559222 | 1.00 | SMN1; SMN2 (0.73) | SMN1; SMN2TAS1R3TAS1R1HDAC3HDAC1 | |
| SCHEMBL31611821 | 0.90 | SMN1; SMN2 (0.75) | SMN1; SMN2TAS1R3TAS1R1HDAC3HDAC1 | |
| SCHEMBL10286708 | 0.88 | TAS1R3 (0.65) | SMN1; SMN2TAS1R3TAS1R1HDAC3HDAC1 | |
| SCHEMBL31611846 | 0.86 | TAS1R3 (0.68) | SMN1; SMN2TAS1R3TAS1R1HDAC3HDAC1 | |
| SCHEMBL1557350 | 0.85 | SMN1; SMN2 (1.00) | SMN1; SMN2TAS1R3TAS1R1HDAC3HDAC1 | |
| SCHEMBL1557437 | 0.85 | SMN1; SMN2 (1.00) | SMN1; SMN2TAS1R3TAS1R1HDAC3HDAC1 | |
| SCHEMBL1558855 | 0.85 | SMN1; SMN2 (1.00) | SMN1; SMN2TAS1R3TAS1R1HDAC3HDAC1 | |
| SCHEMBL1559003 | 0.85 | SMN1; SMN2 (0.51) | SMN1; SMN2HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL28483599 | 0.85 | SMN1; SMN2 (1.00) | SMN1; SMN2TAS1R3TAS1R1HDAC3HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2303830-B1 | MICROBIOLOGICAL METHOD FOR SYNTHESIZING CINNAMOYL AMIDE DERIVATIVES OF AMINO ACIDS | INST RECH DEVELOPPEMENT IRD (FR) | 2014-02-19 | — | — | EP | claimed |
| US-8497302-B2 | Microbiological method for synthesizing cinnamoyl amide derivatives of amino acids | INSTITUT DE RECHERCHE POUR LE DEVELOPMENT (FR) | 2013-07-30 | — | — | US | claimed |
| US-20120142778-A1 | MICROBIOLOGICAL METHOD FOR SYNTHESIZING CINNAMOYL AMIDE DERIVATIVES OF AMINO ACIDS | INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT (FR) | 2012-06-07 | — | — | US | claimed |
| EP-2303830-A1 | MICROBIOLOGICAL METHOD FOR SYNTHESIZING CINNAMOYL AMIDE DERIVATIVES OF AMINO ACIDS | Institut de Recherche pour le Développement (FR) | 2011-04-06 | — | — | EP | claimed |
| WO-2010000964-A1 | MICROBIOLOGICAL METHOD FOR SYNTHESIZING CINNAMOYL AMIDE DERIVATIVES OF AMINO ACIDS | INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT (FR) | 2010-01-07 | — | — | WO | claimed |
| EP-2303830-B1 | MICROBIOLOGICAL METHOD FOR SYNTHESIZING CINNAMOYL AMIDE DERIVATIVES OF AMINO ACIDS | INST RECH DEVELOPPEMENT IRD (FR) | 2014-02-19 | — | — | EP | disclosed |
| US-8497302-B2 | Microbiological method for synthesizing cinnamoyl amide derivatives of amino acids | INSTITUT DE RECHERCHE POUR LE DEVELOPMENT (FR) | 2013-07-30 | — | — | US | disclosed |
| US-20120142778-A1 | MICROBIOLOGICAL METHOD FOR SYNTHESIZING CINNAMOYL AMIDE DERIVATIVES OF AMINO ACIDS | INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT (FR) | 2012-06-07 | — | — | US | disclosed |
| US-8153843-B2 | Antibacterial agents | UNIVERSITY OF WASHINGTON (US) | 2012-04-10 | — | — | US | disclosed |
| US-8153843-B2 | Antibacterial agents | UNIVERSITY OF WASHINGTON (US) | 2012-04-10 | — | — | US | disclosed |
| US-8153843-B2 | Antibacterial agents | UNIVERSITY OF WASHINGTON (US) | 2012-04-10 | — | — | US | disclosed |
| US-8101640-B2 | Antibacterial agents | NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) | 2012-01-24 | — | — | US | disclosed |
| US-20080269221-A1 | ANTIBACTERIAL AGENTS | NOVARTIS VACCINES AND DIAGNOSTICS, INC. | 2008-10-30 | — | — | US | disclosed |
| US-20080269221-A1 | ANTIBACTERIAL AGENTS | NOVARTIS VACCINES AND DIAGNOSTICS, INC. | 2008-10-30 | — | — | US | disclosed |
| US-20080269221-A1 | ANTIBACTERIAL AGENTS | NOVARTIS VACCINES AND DIAGNOSTICS, INC. | 2008-10-30 | — | — | US | disclosed |
| US-7358359-B2 | Antibacterial agents | UNIVERSITY OF WASHINGTON (US) | 2008-04-15 | — | — | US | disclosed |
| US-20070244197-A1 | Antibacterial agents | UNIVERSITY OF WASHINGTON (US) | 2007-10-18 | — | — | US | disclosed |
| US-20070244197-A1 | Antibacterial agents | UNIVERSITY OF WASHINGTON (US) | 2007-10-18 | — | — | US | disclosed |
| US-20070244197-A1 | Antibacterial agents | UNIVERSITY OF WASHINGTON (US) | 2007-10-18 | — | — | US | disclosed |
| US-20060154988-A1 | Antibacterial agents | UNIVERSITY OF WASHINGTON (US) | 2006-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070244197-A1 | Antibacterial agents | MRPL21, SI, PGLS | SMN1; SMN2 2296/4885TAS1R3 4169/4885TAS1R1 3477/4885 |
| US-20080269221-A1 | ANTIBACTERIAL AGENTS | MRPL21, SI, PGLS | SMN1; SMN2 2296/4885TAS1R3 4169/4885TAS1R1 3477/4885 |
| US-20060154988-A1 | Antibacterial agents | MRPL21, SI, PGLS | SMN1; SMN2 2296/4885TAS1R3 4169/4885TAS1R1 3477/4885 |
| US-20120142778-A1 | MICROBIOLOGICAL METHOD FOR SYNTHESIZING CINNAMOYL AMIDE DERIVATIVES OF AMINO ACIDS | ASNS, BCAT2, GLUL | SMN1; SMN2 4566/4885TAS1R3 1736/4885TAS1R1 2160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.